TY - JOUR
T1 - Suppression of Ras-mediated NIH3T3 transformation by p19(ARF) does not involve alterations of cell growth properties
AU - Calabrò, Viola
AU - Parisi, Tiziana
AU - Cristofano, Antonio Di
AU - La Mantia, Girolama
N1 - Funding Information:
recipient of a predoctoral fellowship cofinanced by the `Fondo sociale Europeo' (EEC) and this work is in partial fulfillment of the requirements for the doctoral degree in
PY - 1999/3/25
Y1 - 1999/3/25
N2 - The INK4a gene, one of the most frequently disrupted loci in human cancer, encodes two unrelated proteins, p16(INK4a) and p19(ARF), that both block cell proliferation, p16(INK4a) is a component of the Rb regulatory pathway, while p19(ARF) has been functionally related to p53. Moreover, p16(INK4a) is inactivated in many human tumors, while it has been very recently reported that p19(ARF) null mice develop tumors early in life. We show here that p19(ARF) is able to inhibit the formation of G418-resistant colonies when transfected into human and mouse cell lines expressing wild-type p53, regardless of p16 status. Moreover its amino terminal domain encoded by exon 1β is still sufficient to obtain the same effect. We have analysed the ability of p19(ARF) to interfere with Ras-mediated cellular transformation in the NIH3T3 cell line. Cotransfection of p19(ARF) together with activated ras potently inhibited the formation of transformed foci in a dose-dependent manner. We have also isolated stable NIH3T3 transfectants expressing p19(ARF) and we have measured their growth properties as well as their efficiency of transformation by activated ras. Our results suggest that p19(ARF) can interfere with oncogene-mediated transformation, without significantly affecting NIH3T3 cell growth, at least at the levels of expression achieved in these experiments.
AB - The INK4a gene, one of the most frequently disrupted loci in human cancer, encodes two unrelated proteins, p16(INK4a) and p19(ARF), that both block cell proliferation, p16(INK4a) is a component of the Rb regulatory pathway, while p19(ARF) has been functionally related to p53. Moreover, p16(INK4a) is inactivated in many human tumors, while it has been very recently reported that p19(ARF) null mice develop tumors early in life. We show here that p19(ARF) is able to inhibit the formation of G418-resistant colonies when transfected into human and mouse cell lines expressing wild-type p53, regardless of p16 status. Moreover its amino terminal domain encoded by exon 1β is still sufficient to obtain the same effect. We have analysed the ability of p19(ARF) to interfere with Ras-mediated cellular transformation in the NIH3T3 cell line. Cotransfection of p19(ARF) together with activated ras potently inhibited the formation of transformed foci in a dose-dependent manner. We have also isolated stable NIH3T3 transfectants expressing p19(ARF) and we have measured their growth properties as well as their efficiency of transformation by activated ras. Our results suggest that p19(ARF) can interfere with oncogene-mediated transformation, without significantly affecting NIH3T3 cell growth, at least at the levels of expression achieved in these experiments.
KW - Cell cycle regulation
KW - Cellular transformation
KW - INK4a locus
KW - Tumor suppressor genes
UR - http://www.scopus.com/inward/record.url?scp=0033602466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033602466&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1202532
DO - 10.1038/sj.onc.1202532
M3 - Article
C2 - 10321741
AN - SCOPUS:0033602466
SN - 0950-9232
VL - 18
SP - 2157
EP - 2162
JO - Oncogene
JF - Oncogene
IS - 12
ER -
